BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma
Clinical trial NCT03661554 · UNKNOWN
Trial details
- NCT number
- NCT03661554
- Sponsor
- The Pregene (ShenZhen) Biotechnology Company, Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2018-10-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.